Name
OÜ Kliiniliste Uuringute Keskus
Registry code
11497084
VAT number
EE101249663
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
16.05.2008 (16)
Financial year
01.01-31.12
Capital
100 000.00 €
Activity
72191 - Other research and experimental development on natural sciences and engineering
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ STD & J 10352757 | 100% - 100 000.00 EEK | - | - | Founder |
| Tõnu Põder 13.03.1956 (68) | - | Board member | - | |
| Airi Põder 03.01.1956 (68) | - | - | Indirect ownership |
| 2019 31.12.2020 | 2020 12.01.2022 | 2021 08.02.2023 | 2022 06.09.2023 | |
|---|---|---|---|---|
| Total Revenue | 1 884 684 € | 2 235 614 € | 3 096 298 € | 5 937 999 € |
| Net profit (loss) for the period | 328 534 € | 576 188 € | 1 242 999 € | 3 261 762 € |
| Profit Margin | 17% | 26% | 40% | 55% |
| Current Assets | 778 266 € | 1 192 525 € | 1 650 737 € | 4 268 753 € |
| Fixed Assets | 223 835 € | 159 464 € | 1 180 923 € | 1 157 682 € |
| Total Assets | 1 002 101 € | 1 351 989 € | 2 831 660 € | 5 426 435 € |
| Current Liabilities | 183 054 € | 123 757 € | 617 117 € | 312 244 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 819 047 € | 1 228 232 € | 2 214 543 € | 5 114 191 € |
| Employees | 12 | 14 | 14 | 16 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 2 953 817.78 € | 208 255.09 € | 114 162.76 € | 26 |
| 2023 Q4 | 2 244 638.48 € | 575 583.26 € | 98 818.9 € | 27 |
| 2023 Q3 | 1 397 002.73 € | 247 993.68 € | 94 669.91 € | 26 |
| 2023 Q2 | 1 407 000.44 € | 134 493.21 € | 82 775.6 € | 26 |
| 2023 Q1 | 2 064 174.64 € | 182 997.82 € | 109 358.73 € | 24 |
| 2022 Q4 | 1 943 042.36 € | 151 640.24 € | 80 632.29 € | 24 |
| 2022 Q3 | 1 237 148.89 € | 123 795.37 € | 69 245.25 € | 25 |
| 2022 Q2 | 707 032.08 € | 94 456.65 € | 60 718.04 € | 23 |
| 2022 Q1 | 894 828.68 € | 95 601.02 € | 53 552.13 € | 21 |
| 2021 Q4 | 1 054 666.22 € | 98 113.64 € | 56 770.87 € | 20 |
| 2021 Q3 | 621 911.1 € | 74 301.84 € | 47 988.27 € | 20 |
| 2021 Q2 | 416 734.56 € | 66 674.59 € | 46 033.91 € | 17 |
| 2021 Q1 | 679 397.01 € | 79 982.19 € | 50 962.75 € | 19 |
| 2020 Q4 | 831 392.82 € | 103 483.13 € | 48 841.93 € | 22 |
| 2020 Q3 | 237 155.02 € | 91 493.47 € | 44 901 € | 21 |
| 2020 Q2 | 391 223.95 € | 83 497.76 € | 45 972.48 € | 21 |
| 2020 Q1 | 683 339.24 € | 97 311.29 € | 50 224.43 € | 21 |
